ArticleNeurology(R) neuroimmunology & neuroinflammation2017

Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trial.

Christopher LaGanke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.